Ascendiant Capital Markets Forecasts Strong Price Appreciation for Plus Therapeutics (NASDAQ:PSTV) Stock
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) had its price objective boosted by analysts at Ascendiant Capital Markets from $19.00 to $20.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Other research analysts have also recently issued reports about the company. HC Wainwright decreased their […]
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) had its price objective boosted by analysts at Ascendiant Capital Markets from $19.00 to $20.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Other research analysts have also recently issued reports about the company. HC Wainwright decreased their […]
